Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00388180 · ClinicalTrials.gov registry record
An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 71
- Enrollment target
NCT00388180 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 71 participants.
The verdict
NCT00388180 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
The investigational drugs administered in this study activate proteins called PPARs. Data in the scientific literature on PPARs, as well as animal data and early clinical data generated by GSK with these drugs, suggest that activation of PPARs may cause the body to increase its use of fatty acids for energy, and lead to a reduction in body fat. There are also data to suggest a role for PPARs in regulating lipid (e.g., cholesterol) levels and inflammation. These and other activities of PPARs are being further explored in this clinical study.
Interventions
- DRUG GW501516
- DRUG GW590735
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2004-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00388180
The ClinicalTrials.gov registry entry for NCT00388180 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GW501516 is the first listed.
NCT00388180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00388180 about?
NCT00388180 is a clinical study titled "An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation". The investigational drugs administered in this study activate proteins called PPARs. Data in the scientific literature on PPARs, as well as animal data and early clinical data generated by GSK with these drugs, suggest that activation of PPARs may cause the body to increase its use of fatty acids fo...
What is the current status of trial NCT00388180?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2004-12.
What interventions are being tested in trial NCT00388180?
The interventions under investigation include: GW501516 (DRUG), GW590735 (DRUG).
Who is sponsoring clinical trial NCT00388180?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.